Stay updated on PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Sign up to get notified when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.

Latest updates to the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page
- Check5 days agoChange DetectedThe page history now shows a newer site revision label (v3.6.2) replacing the previous revision (v3.6.0), indicating a minor internal update to the page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe history now shows the study is no longer recruiting participants, with a new revision tag (v3.6.0) added and the previous tag (v3.5.5) removed.SummaryDifference0.4%

- Check26 days agoChange DetectedA new revision entry v3.5.5 appears in the page's revision history. The previous entry v3.5.4 is removed from the history list.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page's revision history now lists v3.5.4 as the latest revision, replacing the previous v3.5.3.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page footer’s software/version indicator is updated from Revision v3.5.2 to Revision v3.5.3, reflecting a maintenance or release update rather than a change to the trial record itself.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision history now includes v3.5.2 and removes v3.5.0.SummaryDifference0.1%

Stay in the know with updates to PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.